POINT BIOPHARMA GLOBAL INC. Financing Cash Flow
POINT BIOPHARMA GLOBAL INC. reported Financing Cash Flow of $45.97 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was -$152.31K, a 100.13% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $52.42K, a 1414.50% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $145.86K, a 15384.50% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $13.46M.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for fiscal 2022 was $130.36M, a 53.74% decline from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for fiscal 2021 was $281.77M, a 883.59% increase from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. net cash provided by (used in) financing activities for fiscal 2020 was $28.65M.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$152.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$99.89K derived: sum of 2 quarters · filed 2023-11-13 | $45.97K 10-Q · filed 2023-11-13 | $13.50M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-06-30 | $52.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $198.28K 10-Q · filed 2023-08-14 | $13.65M derived: sum of 3 quarters · filed 2023-08-14 | $130.55M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-03-31 | $145.86K 10-Q · filed 2023-05-15 | $13.60M derived: sum of 2 quarters · filed 2023-05-15 | $130.50M derived: sum of 3 quarters · filed 2023-11-13 | $130.50M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-12-31 | $13.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $130.35M derived: sum of 2 quarters · filed 2023-11-13 | $130.36M derived: sum of 3 quarters · filed 2023-11-13 | $130.36M 10-K · filed 2023-03-27 | |
| 2022-09-30 | $116.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $116.90M derived: sum of 2 quarters · filed 2023-11-13 | $116.90M 10-Q · filed 2023-11-13 | $116.90M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $3.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.40K 10-Q · filed 2023-08-14 | $4.40K derived: sum of 3 quarters · filed 2023-08-14 | -$4.10M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $942.00 10-Q · filed 2023-05-15 | $942.00 derived: sum of 2 quarters · filed 2023-05-15 | -$4.11M derived: sum of 3 quarters · filed 2023-05-15 | $261.32M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$4.11M derived: sum of 2 quarters · filed 2023-03-27 | $261.32M derived: sum of 3 quarters · filed 2023-03-27 | $281.77M 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $261.32M derived: sum of 2 quarters · filed 2022-11-14 | $281.77M 10-Q · filed 2022-11-14 | $281.77M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $265.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $285.88M 10-Q · filed 2022-08-12 | $285.88M derived: sum of 3 quarters · filed 2022-08-12 | $303.27M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $20.45M 10-Q · filed 2022-05-13 | $20.45M derived: sum of 2 quarters · filed 2022-05-13 | $37.84M derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-04 | $17.39M derived: sum of 2 quarters · filed 2021-11-12 | $137.10M 10-K · filed 2021-03-04 | $28.65M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $17.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $137.10M 10-Q · filed 2020-11-02 | $28.65M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $82.70K 10-Q · filed 2020-08-20 | $11.25M 10-Q · filed 2021-08-13 |